Most Recent
Star Entertainment Group has been hit with a shareholder class action for allegedly painting itself as the "cleanskin" of the gambling industry despite alleged lax compliance and links to money laundering and organised crime, amid a damning public inquiry by the gambling regulator that has led to the resignation of its CEO.
A $98 million settlement reached in two franchisee class actions against 7-Eleven is “appropriate" given the likelihood that the convenience store giant would have lost at trial, according to a contradictor who urged the court to reject a $25 million cut sought by the funder that backed the litigation.
The plaintiff in a class action against Volkswagen over allegedly deadly Takata airbags has told an appeals court his case was misunderstood by the trial judge, who found he failed to prove that cars fitted with the airbags were not of acceptable quality.
Litigation funder Galactic should receive a $15 million commission for its work on two franchisee class actions against convenience store giant 7-Eleven, instead of the $25 million it has asked for, a court has heard.
Damages owed to a millionaire couple by JD Group over a "deliberately misleading" rendering of a $9.58 million apartment in South Yarra, Melbourne will be put on ice pending the outcome of the property developer's appeal.
Peters Ice Cream has been hit with a $12 million penalty after admitting to entering an anti-competitive exclusive agreement for distribution of its single serve ice creams to service stations and convenience stores across Australia.
Epic Games has argued in favour of steaming ahead with a trial in its competition case against Apple while its parallel case against Google remains in the embryonic stage, but the tech giants say Google's litigation should catch up in the hopes that the court can hear a joint trial or hold contemporaneous hearings.
A judge has questioned whether the lead applicant in a class action over sleep apnea machines with alleged safety defects was “appropriately resourced” to run the case against health tech giant Philips.
The ACCC has refused to authorise a patent settlement and license agreement between Bristol-Myers Squibb unit Celgene and two generic drug makers who sued to invalidate the patents for its blockbuster cancer drug Revlimid, saying it could distort competition between generic drug makers.
Group members in a class action by Papua New Guinea workers against labour hire firm CoreStaff would get less than half of a $6.4 million settlement if the funder that backed the case seeks a common funder order for a 35 per cent commission.